A Randomized Trial Administering Oxytocin vs Placebo as add-on to Antipsychotics in Patients With Schizophrenia and Schizo-affective Disorder
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Oxytocin (Primary)
- Indications Schizoaffective disorder; Schizophrenia
- Focus Pharmacogenomic; Therapeutic Use
- Acronyms OXY-S-01
- 25 Nov 2013 Biomarkers information updated
- 21 May 2012 New trial record